白内障超声乳化摘除联合人工晶状体植入术对治疗糖尿病代谢性白内障合并屈光不正的安全性分析

目的：探讨白内障超声乳化摘除联合人工晶状体植入术对治疗糖尿病代谢性白内障合并屈光不正的安全性。方法：采用回顾性分析方法，选取本院2011年1月-2013年1月收治的68例（98眼）糖尿病代谢性白内障合并屈光不正患者的临床资料，随机选取同时期收治的68例（98眼）非糖尿病白内障合并屈光不正患者，均给予白内障超声乳化摘除联合人工晶状体植入术治疗，比较两组患者的术后视力、术后并发症以及屈光不正的矫正情况。结果：糖尿病组的98眼中，术后矫正视力0.5以上者有40眼，占40.82%，非糖尿病组98眼中，术后矫正视力0.5以上者45眼，占45.92%，两组患者在术后视力提高程度以及屈光不正的矫正情况上比较差异无统计学意义（P＆gt;0.05）；糖尿病组并发症有23眼，占23.47%；非糖尿病组并发症有12例，占12.24%，两组患者在术后并发症上比较差异有统计学意义（P＆lt;0.05），所有并发症均经过对症处理，恢复正常，均未影响视力。结论：对于糖尿病代谢性白内障合并屈光不正患者，在术前经过适当饮食控制以及使用降血糖药物，使血糖控制在稳定范围内，给予白内障超声乳化摘除联合人工晶状体植入术是安全可行的，能够同时治疗白内障及矫正屈光不正，提高患者视力，同时为对患者糖尿病视网膜病变进行诊治做好准备。

Safety Analysis of Intraocular Lens Implantation for the Treatment of Diabetes and Metabolic Cataract and Refractive Error Extraction ;with Phacoemulsification

Objective：To investigate the cataract phacoemulsification and safety analysis of intraocular lens implantation for the treatment of diabetes and metabolic cataract and refractive error. Method：68 patients（98 eyes）with diabetes and metabolic cataract and refractive error were selected in our hospital from January 2011 to January 2013,68 cases（98 eyes）of non diabetic cataract and ametropia were randomly selected.All patients were treated with phacoemulsification combined with treatment of intraocular lens implantation,postoperative vision,postoperative complications and refractive correction of two groups were compared.Result：Diabetes mellitus group of 98 eyes,the corrected visual acuity was more than 0.5 in 40 eyes,accounting for 40.82%,non diabetes mellitus group 98 eyes,the corrected visual acuity of more than 0.5 in 45 eyes,accounting for 45.92%,two of patients in the postoperative visual acuity and refractive error were not significantly different,the difference was nostatistically significant（P＆gt;0.05）.Diabetes mellitus group（98 eyes）of complications in 23 eyes,accounting for 23.47%,non diabetic complications in 12 cases,accounting for 12.24%,the difference had statistically significant（P＆lt;0.05）,all the complications were recovered to normal after symptomatic treatment,all did not affect vision. Conclusion：The diabetic metabolic cataract and refractive errors in patients with preoperative through proper diet control and hypoglycemic drug use quantity,make blood sugar control in stable,given the phacoemulsification and intraocular lens implantation is safe and feasible,and can improve eyesight,and provide the basis for the treatment of ocular fundus diseases.